Vanderbilt Center for Arrythmia Research and Therapeutics
Welcome to VanCART
Vanderbilt Center for Arrhythmia Research and Therapeutics (VanCART) is an interdisciplinary center aiming to understand mechanisms predisposing to abnormal heart rhythms and using this information for optimal personalized patient care.
Our Mission
Our mission is to provide an intellectual home and infrastructure for researchers to improve diagnosis and personalized therapy for patients with genetic arrhythmia disorders, and training for the next generation of leaders in arrhythmia biology.
- Education
- Patient Care
- Research
- Basic
- Translational
- Clinical
Vanderbilt Medicine is an internationally recognized leader in the field of arrhythmia research and therapeutics. Vanderbilt investigators have been at the forefront of basic and clinical discovery in mechanisms underlying arrhythmias and their variable responses to treatments, notably the development of proarrhythmia defined by CAST (in which Vanderbilt was a leading participant) and by studies of QT prolongation.
VanCART Director
Bjorn Knollmann, MD, PhD
Professor of Medicine
Department of Medicine
Division of Genetic Medicine and Clinical Pharmacology
William Stokes Chair in Experimental Therapeutics
Contact
Beau Woodall
Program Manager
Email beau.m.woodall@vanderbilt.edu